Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial.
Diabetes Care. 2021 Jun;44(6):1334-1343. doi: 10.2337/dc20-2887. Epub 2021 Apr 15.
Diabetes Care. 2021.
PMID: 33858855
Free PMC article.
Clinical Trial.
L-carnitine infusion does not alleviate lipid-induced insulin resistance and metabolic inflexibility.
Bruls YMH, Op den Kamp YJM, Phielix E, Lindeboom L, Havekes B, Schaart G, Moonen-Kornips E, Wildberger JE, Hesselink MKC, Schrauwen P, Schrauwen-Hinderling VB.
Bruls YMH, et al. Among authors: op den kamp yjm.
PLoS One. 2020 Sep 25;15(9):e0239506. doi: 10.1371/journal.pone.0239506. eCollection 2020.
PLoS One. 2020.
PMID: 32976523
Free PMC article.
Clinical Trial.
Item in Clipboard
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism.
Op den Kamp YJM, Gemmink A, de Ligt M, Dautzenberg B, Kornips E, Jorgensen JA, Schaart G, Esterline R, Pava DA, Hoeks J, Schrauwen-Hinderling VB, Kersten S, Havekes B, Koves TR, Muoio DM, Hesselink MKC, Oscarsson J, Phielix E, Schrauwen P.
Op den Kamp YJM, et al.
Mol Metab. 2022 Dec;66:101620. doi: 10.1016/j.molmet.2022.101620. Epub 2022 Oct 21.
Mol Metab. 2022.
PMID: 36280113
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite